Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Washam, Jeffrey B et al.

The lancet. Volume 385:Issue 9985 (2015); pp 2363-2370 -- Elsevier

Online access